Torrent Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Torrent Pharmaceuticals has a total shareholder equity of ₹75.0B and total debt of ₹30.5B, which brings its debt-to-equity ratio to 40.6%. Its total assets and total liabilities are ₹150.9B and ₹75.8B respectively. Torrent Pharmaceuticals's EBIT is ₹28.0B making its interest coverage ratio 9.8. It has cash and short-term investments of ₹12.4B.
Key information
40.6%
Debt to equity ratio
₹30.48b
Debt
| Interest coverage ratio | 9.8x |
| Cash | ₹12.35b |
| Equity | ₹75.04b |
| Total liabilities | ₹75.84b |
| Total assets | ₹150.88b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 500420's short term assets (₹58.8B) exceed its short term liabilities (₹48.5B).
Long Term Liabilities: 500420's short term assets (₹58.8B) exceed its long term liabilities (₹27.4B).
Debt to Equity History and Analysis
Debt Level: 500420's net debt to equity ratio (24.2%) is considered satisfactory.
Reducing Debt: 500420's debt to equity ratio has reduced from 118.6% to 40.6% over the past 5 years.
Debt Coverage: 500420's debt is well covered by operating cash flow (111.8%).
Interest Coverage: 500420's interest payments on its debt are well covered by EBIT (9.8x coverage).